Article Details

To save itself, might Medicare deny coverage of controversial new Alzheimer's drug?

Retrieved on: 2021-06-28 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

To save itself, might Medicare deny coverage of controversial new Alzheimer's drug?. View article details on hiswai:

Excerpt

CMS is reviewing the FDA's decision and “will have more information soon,” an agency spokesperson told McKnight's Long-Term Care News on Friday.

Article found on: www.mcknights.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo